Omnicell’s OMCL increasing cost of production continues to hamper the company’s margin performance. Weak hospital spending trends and tough competition also pose threats. The stock currently has a ...
Zacks Investment Research on MSN
Omnicell (OMCL) may find a bottom soon, here's why you should buy the stock now
Shares of Omnicell (OMCL) have been struggling lately and have lost 6.3% over the past two weeks. However, a hammer chart ...
Omnicell's OMCL strategic acquisitions and partnerships support each of the three pillars of the company’s strategy. Yet, the increasing cost of production continues to hamper the company’s margin ...
Thank you for standing by. My name is John, and I'll be your conference operator today. Please note, that today's meeting is being recorded. All lines have been placed on mute to prevent any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results